The renin-angiotensin system (RAS) is a major endocrine system, which has a central role in the regulation of body fluids, electrolyte balance and thereby blood pressure (BP). 1 Angiotensin II ...

Gland Pharma receives USFDA approval for Angiotensin II Acetate Injection, a generic drug with exclusive rights and high sales. The drug is used to raise blood pressure in adults with septic or ...

Researchers at the University of Tsukuba have developed a novel mouse model that allows them to induce dysfunction in only ...

Generic injectable focused Gland Pharma’s version of La Jolla Pharma’s Giapreza injection for increasing blood pressure in adults with septic or other distributive shock has received U.S. Food ...

Angiotensin II-receptor antagonists are well tolerated and are as effective as ACE inhibitors in decreasing blood pressure. Introduction. High blood pressure affects over 50 million Americans, but ...

Background Mobility limitation is prevalent in patients with heart failure (HF), but the dose-response relationship between ...

Gland Pharma receives US FDA approval for angiotensin II acetate injection: Our Bureau, Mumbai Wednesday, June 4, 2025, 16:45 Hrs [IST] Gland Pharma Limited, a generic injectable & ophthalmic- focused ...

Earlier this month, the company's material subsidiary Cenexi also received a final inspection report from France's drug ...

She is among many patients now asking why, with no apparent change in their blood test results, chronic kidney disease (CKD) ...

Several AT-II-receptor antagonists have been compared with several ACE inhibitors ( Table 2). A double- blind, multicenter, randomized study of 227 patients with mild to moderate hypertension ...

The newly approved product is a generic version of GIAPREZA, originally developed by La Jolla Pharma LLC, and is intended for use in critical care settings.